Pioneer of COVID-19 Treatment Sued Hospital Over Prescription Ban

Translated by: MOS Gospel Team – lilian89

On Nov. 18, Dr. Paul Marek, chief medical officer of the Frontline Covid Intensive Care Alliance, testified at a Virginia Circuit Court hearing.

On Nov. 9, Dr. Marek filed a lawsuit in Virginia Circuit Court against the Centara Health System, Norfolk General Hospital, who prohibited physicians from providing ivermectin to Covid-19 patients.

On Nov. 9, Dr. Marek filed a lawsuit in Virginia Circuit Court against the Centara Health System, Norfolk General Hospital, who prohibited physicians from providing ivermectin to Covid-19 patients.

Dr. Marek has been a critical care unit chief at Norfolk General Hospital for more than 16 years. Since the Covid-19 outbreak, Dr. Marek has worked with other collaborators to compare and analyze numerous therapeutic methods, published clinical trials, and proposed guidelines for Covid-19 prevention and treatment based on ivermectin fluvoxamine and other medications.

Ivermectin has successfully prevented the Covid-19 spread and saved thousands of lives in India and Japan. However, Norfolk General Hospital, where Dr. Marek works, released an administrative order to ban ivermectin for Covid-19 treatment. Dr. Marek testified that such a ban impedes the patients’ free will to choose medication under physician guidance that may cause tragic sacrifices without effective medicines.

According to Virginia law, primary care physicians are authorized to provide appropriate treatment options to patients.

Proofread by: Wenfei

Edited by: Wenfei

Posted by: Wenfei

Reference: https://www.lifesitenews.com/news/top-doctor-banned-from-treating-covid-patients-with-ivermectin-brings-lawsuit-to-court-today/

https://covid19criticalcare.com/about/the-flccc-physicians/

https://www.wtkr.com/investigations/norfolk-doctor-leading-charge-for-controversial-covid-19-treatment-faces-off-against-sentara-in-court

Disclaimer: This article only represents the author’s view. Gnews is not responsible for any legal risks.

0 Comments
Inline Feedbacks
View all comments